Translate
Processa Pharmaceuticals Inc
About
Processa Pharmaceuticals Inc (NASDAQ:PCSA) — investor relations, events, news, and company updates on 6ix.
Latest News
Jan 12 2026
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
Jan 5 2026
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
Dec 17 2025
Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer
Nov 5 2025
Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025
Aug 7 2025
Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies
Financials
Revenue
$0
Market Cap
$7.45 M
EPS
-10.36
